Hypocomplementaemic urticarial vasculitis: successful treatment with cyclophosphamide-dexamethasone pulse therapy
- PMID: 9892919
- DOI: 10.1046/j.1365-2133.1998.02473.x
Hypocomplementaemic urticarial vasculitis: successful treatment with cyclophosphamide-dexamethasone pulse therapy
Abstract
Systemic hypocomplementaemic urticarial vasculitis unresponsive to several immunosuppressive and immunomodulatory drugs was seen in two women aged 43 and 45 years. Cyclophosphamide-dexamethasone pulse therapy was started in both patients and resulted in significant clinical improvement. The pulse treatment was well tolerated in both patients and no major adverse effects occurred. These cases indicate that cyclophosphamide-dexamethasone pulse therapy is efficient in the treatment of hypocomplementaemic urticarial vasculitis.
Comment in
-
Mycophenolate mofetil is effective for maintenance therapy of hypocomplementaemic urticarial vasculitis.Br J Dermatol. 2000 Dec;143(6):1324. doi: 10.1046/j.1365-2133.2000.03913.x. Br J Dermatol. 2000. PMID: 11122046 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources